姜黃素對(duì)魚藤酮誘導(dǎo)的帕金森病SH-SY5Y細(xì)胞模型的抗氧化應(yīng)激作用及其機(jī)制
[Abstract]:Background and objective Parkinson disease (PD) is a neurodegenerative disease whose main pathological feature is the death of the neurons of the substantia nigra (Dopamine, DA) and the degeneration of the nigrostriatal pathway. The depletion of the nigrostriatal pathway and the obvious inhibitory effect of the substantia nigra on the thalamus to the muscle movement and muscle tension The results show that many factors such as oxidative stress, mitochondrial dysfunction, inflammatory response, and proteasome dysfunction are involved in the occurrence of PD, but the specific mechanism is not completely clear. Curcumin is the effective component of curcumin and the latter has been widely used. Used as a food seasoning and traditional herbal medicine. Curcumin is a phenolic pigment extracted from the rhizomes of turmeric. It has a variety of pharmacological effects such as anti-inflammatory, antioxidant, and free radical scavenging. The study shows that curcumin can inhibit the formation of active MPP+ induced intracellular oxygen by inducing the expression of Bcl-2 to maintain the mitochondrial membrane. The stability of the potential, reducing the release of cytochrome C, eventually plays a role in antagonism to oxidative stress. Meanwhile curcumin can increase the level of glutathione, inhibit lipid peroxidation and protect the dopamine neurons. Lysine residue acetylation plays an important role in the modification and regulation of protein translation. It is in vivo It has been reported that more than 20% of the mitochondria in mitochondria have acetylation,.Sir T3 is a kind of class III deacetylase dependent on nicotinamide adenine dinucleotide (NAD), which is one of the members of the Sirtuin family, which is one of the members of the Sirtuin family, which are mainly in the heart, brain, kidney and liver. Sirt3 can deacetylation of those acetylated mitochondrial proteins to maintain the normal physiological function of mitochondria, and can effectively reduce the occurrence of diseases caused by oxidative stress load. The mechanism for reducing oxidative stress damage may activate the O subgroup 3A (FOXO3a) by acetylated activation. Forkhead box O 3a) up regulate the expression of ROS scavenging system such as MnSOD and catalase catalase (CAT). Earlier experiments have proved that curcumin can protect the rat model of rotenone induced chronic PD SD rat by regulating the expression of Sirt3. The expression of T to inhibit the damage or apoptosis of rotenone induced SH-SY5Y cells is one of the problems to be discussed in this study. Therefore, this study selected curcumin to treat the cell model of rotenone induced SH-SY5Y, and detected the expression of cell vitality, ROS content, SIRT3, FOXO3a, Mn-SOD and CAT protein, and explored the model of curcumin to the PD cell model. The protective effect of curcumin, the relationship between curcumin, SIRT3, FOXO3a and ROS scavenging system and its related mechanism, provide theoretical basis and new ideas for clinical treatment. Materials and methods first set up SH-SY5Y cell model, and then divide SH-SY5Y cells into control group (without drug treatment), and rotenone (final concentration 0.1uM) model. Group, curcumin pretreatment group (the final concentration was 0.5 mu M, 1 mu M, 5 mu M, 10 M) in 6 groups. The cell viability was detected by MTT, the content of ROS was detected by flow cytometry, and the expression of SIRT3, FOXO3a and Mn-SOD and CAT protein in cell was detected by Western-blot method. The protective effect of ketone induced cell damage was significantly higher than that of rotenone injury group (P0.01), and the effect of 1.0umol/L was the strongest. When 5.0umol/L, the protective effect began to decrease, and the activity of SH-SY5Y cells was reduced, but with rotenone, the activity of rotenone in SH-SY5Y cells was more than the damage of rotenone. Group increased, still play the role of protective cells, but did not show synergistic damage, but the difference was not statistically significant (P0.05).2. flow cytometry to detect the effect of intracellular ROS content: after 0.1 u mol/L rotenone treated cells 24h, the level of intracellular ROS was higher than the control group (P0.01); 0.5 mu mol/L, 1 mu mol/L curcumin treatment group is more blank. The cell ROS in the control group and rotenone group decreased (P0.01), and the difference was not statistically significant between the 5 mu mol/L, 10 mol/L curcumin treatment group and the rotenone group (P0.05) 3.Western-blot detection SIRT3, FOXO3a, Mn-SOD and CAT protein expression: the rotenone treatment group was lower than the control group, 0.5 Mu mol/L, 1 mu mol/L curcumin treatment group compared with the control group, the fish Teng group. The expression of ketone group was higher, the difference was statistically significant (P0.01). There was no significant difference between 5 and 10 mol/L groups compared with rotenone group (P0.05). Conclusion 1. rotenone has obvious neurotoxicity, its toxic effect is concentration dependent: the appropriate concentration can be used to prepare PD model of SH-SY5Y cells, and the cell death will be directly caused by high concentration. .2. in the PD model of rotenone induced SH-SY5Y cells, the activity of cells decreased, the content of ROS in the cells increased. The expression of Sirt3, FOXO3a, Mn-SOD and CAT reduced.3. curcumin by inducing SIRT3 expression by inducing its deacetylation activation FOXO3a. Protect.
【學(xué)位授予單位】:鄭州大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類號(hào)】:R742.5
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 陳春暖;陳祥榮;蔡若蔚;曹學(xué)兵;王濤;;魚藤酮建立帕金森病細(xì)胞模型的方法研究[J];中國(guó)神經(jīng)免疫學(xué)和神經(jīng)病學(xué)雜志;2015年06期
2 竺飛燕;張雄;王百辰;胡智偉;;魚藤酮誘導(dǎo)PC12細(xì)胞凋亡及線粒體膜電位變化[J];中國(guó)藥理學(xué)通報(bào);2014年02期
3 趙江浩;趙斌;;細(xì)胞外α-突觸核蛋白的特點(diǎn)及其與帕金森病的關(guān)系[J];醫(yī)學(xué)理論與實(shí)踐;2012年18期
4 王國(guó)恩;翟羽佳;何蓉蓉;栗原博;;SirT3調(diào)節(jié)氧化應(yīng)激作用[J];中國(guó)藥理學(xué)通報(bào);2012年10期
5 趙素玲;王洪新;周振華;喻曉春;魯美麗;宋瑩;張晶;;黃芪多糖對(duì)異丙腎上腺素誘導(dǎo)的乳大鼠心肌細(xì)胞肥大的保護(hù)作用[J];中國(guó)藥理學(xué)通報(bào);2011年12期
6 王少君;羅琴;王加才;萬(wàn)金城;張江偉;李增潮;張洵岳;韓霞;彭國(guó)光;;α-synuclein表達(dá)增高與免疫炎性反應(yīng)在帕金森病發(fā)病機(jī)制中的作用[J];中國(guó)老年學(xué)雜志;2011年01期
7 崔群力;孫圣剛;;姜黃素通過(guò)抗氧化作用拮抗魚藤酮致PC12細(xì)胞損傷的研究[J];華中科技大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2010年01期
8 余美榮;蔣福升;丁志山;;姜黃素的研究進(jìn)展[J];中草藥;2009年05期
9 單悌超;任玉嬌;于學(xué)慧;袁彥平;;帕金森病模型研究進(jìn)展[J];中國(guó)老年學(xué)雜志;2009年09期
10 Stig Bengmark;劉青;;植物源保護(hù)劑姜黃素的研究進(jìn)展[J];現(xiàn)代藥物與臨床;2009年01期
,本文編號(hào):2161081
本文鏈接:http://sikaile.net/yixuelunwen/shenjingyixue/2161081.html